Cancer Immunotherapy

Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer
Colby S. Shemesh, Pascal Chanu, Kris Jamsen, Russ Wada, Gianluca Rossato, Francis Donaldson, Amit Garg, Helen Winter, Jane Ruppel, Xin Wang, Rene Bruno, Jin Jin, Sandhya Girish

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 314; DOI: 10.1186/s40425-019-0791-x
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19^high B lymphocytes
Yu-Li Chen, Han-Wei Lin, Chung-Liang Chien, Yen-Ling Lai, Wei-Zen Sun, Chi-An Chen, Wen-Fang Cheng

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 313; DOI: 10.1186/s40425-019-0744-4
Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
Alexandra Berger, Sarah J. Colpitts, Melanie S. S. Seabrook, Caren L. Furlonger, Maura B. Bendix, Joshua M. Moreau, William M. McKillop, Jeffrey A. Medin, Christopher J. Paige

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 355; DOI: 10.1186/s40425-019-0777-8
EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy
Kerstin Kapp, Barbara Volz, Michael A. Curran, Detlef Oswald, Burghardt Wittig, Manuel Schmidt

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 5; DOI: 10.1186/s40425-018-0470-3
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Jeffrey M. Conroy, Sarabjot Pabla, Mary K. Nesline, Sean T. Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo, Yirong Wang, Felicia L. Lenzo, Wiam Bshara, Maya Khalil, Grace K. Dy, Katherine G. Madden, Keisuke Shirai, Konstantin Dragnev, Laura J. Tafe, Jason Zhu, Matthew Labriola, Daniele Marin, Shannon J. McCall, Jeffrey Clarke, Daniel J. George, Tian Zhang, Matthew Zibelman, Pooja Ghatalia, Isabel Araujo-Fernandez, Luis de la Cruz-Merino, Arun Singavi, Ben George, Alexander C. MacKinnon, Jonathan Thompson, Rajbir Singh, Robin Jacob, Deepa Kasuganti, Neel Shah, Roger Day, Lorenzo Galluzzi, Mark Gardner, Carl Morrison

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 18; DOI: 10.1186/s40425-018-0489-5
Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation
Hua Jing, Michael Hettich, Simone Gaedicke, Elke Firat, Mark Bartholomä, Gabriele Niedermann

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 55; DOI: 10.1186/s40425-019-0537-9
Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity
Elena E. Tchekneva, Mounika U.L. Goruganthu, Roman V. Uzhachenko, Portia L. Thomas, Anneliese Antonucci, Irina Chekneva, Michael Koenig, Longzhu Piao, Anwari Akhter, Maria Teresa P. de Aquino, Parvathi Ranganathan, Nicholas Long, Thomas Magliery, Anna Valujskikh, Jason V. Evans, Rajeswara R. Arasada, Pierre P. Massion, David P. Carbone, Anil Shanker, Mikhail M. Dikov

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 95; DOI: 10.1186/s40425-019-0566-4
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
Stefanie K. Wculek, Joaquín Amores-Iniesta, Ruth Conde-Garrosa, Sofía C. Khouili, Ignacio Melero, David Sancho

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 100; DOI: 10.1186/s40425-019-0565-5
Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide
Chanju Lee, Hyunju Jeong, Younghyeon Bae, Kyungmoon Shin, Sinwoo Kang, Hwikyung Kim, Jayoung Oh, Hyunsu Bae

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 147; DOI: 10.1186/s40425-019-0610-4
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
Erik Voets, Marc Paradé, David Lutje Hulsik, Sanne Spijkers, Wout Janssen, Joost Rens, Inge Reinieren-Beeren, Gilbert van den Tillaart, Sander van Duijnhoven, Lilian Driessen, Maurice Habraken, Peter van Zandvoort, Joost Kreijtz, Paul Vink, Andrea van Elsas, Hans van Eenennaam

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 340; DOI: 10.1186/s40425-019-0772-0

Main menu

Cancer Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cancer Immunotherapy

Pages